glp-1 nejm Orforglipron, an Oral Small-Molecule Receptor Agonist, in Early Type 2 Diabetes NEJM Clinician: Should we hold

This question is crucial for many women considering its use during this sensitive time

ConsumerLab Finds 29% Have Inaccurate Labels White Plains, NY, April 30, 2026 Protein powders and ready-to-drink shakes are a convenient way to get more protein, but new testing by ConsumerLab.com shows that some consumers may also get more cholesterol, sodium, or sugar than they bargained for

Machine learning identifies novel signatures of antifungal drug resistance in Saccharomycotina yeasts

Disease stage and remaining tissue considerations Early disease with substantial viable tissue: Maximum benefit from protective mechanisms

Brand-name drugs command high prices because their developers still enjoy monopolies on their production and sale

Injection-related risks: The FDA has highlighted concerns about using the dietary ingredient glutathione in compounded sterile injectable drugs, as it may cause unintended health consequences ranging from fever to death